| 06/02/2026 4:31 PM | Sabatini Brent (2037272) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/02/2026 4:35 PM | Napolitano Janet (1821008) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/01/2026 2:03 PM | Sabatini Brent (2037272) Reporting Vir Biotechnology (1706431) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/01/2026 12:04 PM | Napolitano Janet (1821008) Reporting Vir Biotechnology (1706431) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 05/28/2026 6:23 PM | BISCHOFBERGER NORBERT W (1190273) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/28/2026 6:24 PM | Farid Ramy (1797707) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/28/2026 6:24 PM | Hatfield Jeffrey S. (1609879) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/28/2026 6:25 PM | MORE ROBERT J (1207792) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/28/2026 6:25 PM | Napolitano Janet (1821008) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/28/2026 6:25 PM | Sigal Charles Elliott (1661908) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 05/28/2026 8:01 AM | Vir Biotechnology (1706431) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for VIR and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Vir Biotechnology and its competitors with MarketBeat's FREE daily newsletter.
|
| 05/15/2026 8:00 PM | SB INVESTMENT ADVISERS (0) UK Vir Biotechnology (1706431) Subject | Form SCHEDULE 13G/A | |
| 05/04/2026 11:35 AM | SATO VICKI L (1197020) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/30/2026 4:43 PM | De Backer Marianne (1797819) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/29/2026 2:50 PM | VANGUARD PORTFOLIO MANAGEMENT LLC (2100121) Filed by Vir Biotechnology (1706431) Subject | Form SCHEDULE 13G | |
| 04/16/2026 3:05 PM | Vir Biotechnology (1706431) Filer | Form ARS | |
| 04/16/2026 7:46 AM | Vir Biotechnology (1706431) Filer | Form DEF 14A | |
| 04/16/2026 7:49 AM | Vir Biotechnology (1706431) Filer | Form DEFA14A | |
| 04/07/2026 3:50 PM | De Backer Marianne (1797819) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 04/06/2026 2:23 PM | De Backer Marianne (1797819) Reporting Vir Biotechnology (1706431) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 04/02/2026 9:46 AM | SATO VICKI L (1197020) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/27/2026 12:55 PM | VANGUARD GROUP INC (102909) Filed by Vir Biotechnology (1706431) Subject | Form SCHEDULE 13G/A | |
| 03/24/2026 3:35 PM | Sabatini Brent (2037272) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/23/2026 2:49 PM | O'Byrne Jason (1871145) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/23/2026 8:42 AM | Sabatini Brent (2037272) Reporting Vir Biotechnology (1706431) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 03/03/2026 11:10 AM | SATO VICKI L (1197020) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 03/02/2026 8:01 AM | Vir Biotechnology (1706431) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/26/2026 4:17 PM | Vir Biotechnology (1706431) Filer | Form 424B5 | |
| 02/26/2026 4:20 PM | Vir Biotechnology (1706431) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/25/2026 8:00 PM | SVF Endurance (0) Cayman Vir Biotechnology (1706431) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/25/2026 9:48 AM | de Verneuil Vanina (2036234) Reporting Vir Biotechnology (1706431) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/25/2026 8:48 AM | Eisner Mark (1834161) Reporting Vir Biotechnology (1706431) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/24/2026 6:09 PM | De Backer Marianne (1797819) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/24/2026 6:10 PM | de Verneuil Vanina (2036234) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/24/2026 6:11 PM | Eisner Mark (1834161) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/24/2026 6:12 PM | O'Byrne Jason (1871145) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/24/2026 6:13 PM | Sabatini Brent (2037272) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/24/2026 4:16 PM | Eisner Mark (1834161) Reporting Vir Biotechnology (1706431) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/24/2026 3:57 PM | O'Byrne Jason (1871145) Reporting Vir Biotechnology (1706431) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/24/2026 3:53 PM | Sabatini Brent (2037272) Reporting Vir Biotechnology (1706431) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/24/2026 3:33 PM | SATO VICKI L (1197020) Reporting Vir Biotechnology (1706431) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
$30 stock to buy before Starlink goes public (WATCH NOW!) (Ad) A little-known stock pick with money-doubling potential over the next year is revealed for free in the first three minutes of a new video. This company is a critical piece of Elon Musk's fast-growing Starlink technology. It could climb 100 percent or more over the next year as Elon brings Starlink public in what may be the biggest IPO in history. No credit card is required to get the ticker. Watch the free video to get the ticker today. |
| 02/24/2026 3:42 PM | de Verneuil Vanina (2036234) Reporting Vir Biotechnology (1706431) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/23/2026 4:27 PM | Vir Biotechnology (1706431) Filer | Form 10-K Annual report pursuant to Section 13 or 15(d) | |
| 02/23/2026 4:29 PM | Vir Biotechnology (1706431) Filer | Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
| 02/23/2026 4:16 PM | Vir Biotechnology (1706431) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 02/23/2026 3:52 PM | O'Byrne Jason (1871145) Reporting Vir Biotechnology (1706431) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/23/2026 3:32 PM | De Backer Marianne (1797819) Reporting Vir Biotechnology (1706431) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/23/2026 3:34 PM | Eisner Mark (1834161) Reporting Vir Biotechnology (1706431) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/23/2026 3:18 PM | Sabatini Brent (2037272) Reporting Vir Biotechnology (1706431) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/23/2026 3:22 PM | de Verneuil Vanina (2036234) Reporting Vir Biotechnology (1706431) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 02/18/2026 2:38 PM | Sabatini Brent (2037272) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 02/03/2026 11:28 AM | SATO VICKI L (1197020) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/14/2026 8:00 PM | SVF Endurance (0) Cayman Vir Biotechnology (1706431) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 01/12/2026 7:07 AM | Vir Biotechnology (1706431) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 01/05/2026 12:57 PM | SATO VICKI L (1197020) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 01/02/2026 3:29 PM | SATO VICKI L (1197020) Reporting Vir Biotechnology (1706431) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 12/16/2025 3:25 PM | Vir Biotechnology (1706431) Filer | Form 8-K Current report pursuant to Section 13 or 15(d) | |
| 12/02/2025 6:48 PM | SATO VICKI L (1197020) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/26/2025 3:30 PM | SVF Endurance (0) Cayman Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/25/2025 8:00 PM | SVF Endurance (0) Cayman Vir Biotechnology (1706431) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/18/2025 1:47 PM | O'Byrne Jason (1871145) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/17/2025 2:20 PM | O'Byrne Jason (1871145) Reporting Vir Biotechnology (1706431) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/07/2025 2:27 PM | de Verneuil Vanina (2036234) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/05/2025 4:15 PM | Vir Biotechnology (1706431) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 11/05/2025 8:47 AM | de Verneuil Vanina (2036234) Reporting Vir Biotechnology (1706431) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 11/04/2025 6:40 PM | de Verneuil Vanina (2036234) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/04/2025 10:58 AM | SATO VICKI L (1197020) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 11/03/2025 2:30 PM | de Verneuil Vanina (2036234) Reporting Vir Biotechnology (1706431) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 10/30/2025 3:30 PM | SVF Endurance (0) Cayman Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/28/2025 3:30 PM | SVF Endurance (0) Cayman Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/24/2025 3:30 PM | SVF Endurance (0) Cayman Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/22/2025 3:30 PM | SVF Endurance (0) Cayman Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/21/2025 8:00 PM | SVF Endurance (0) Cayman Vir Biotechnology (1706431) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 10/17/2025 3:15 PM | SVF Endurance (0) Cayman Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/14/2025 3:30 PM | SVF Endurance (0) Cayman Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/09/2025 3:30 PM | SVF Endurance (0) Cayman Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/07/2025 3:30 PM | SVF Endurance (0) Cayman Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/03/2025 4:00 PM | SVF Endurance (0) Cayman Vir Biotechnology (1706431) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 10/02/2025 10:53 AM | SATO VICKI L (1197020) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 10/01/2025 3:32 PM | SATO VICKI L (1197020) Reporting Vir Biotechnology (1706431) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 09/03/2025 12:50 PM | SATO VICKI L (1197020) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 08/06/2025 4:31 PM | Vir Biotechnology (1706431) Filer | Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
| 08/04/2025 11:27 AM | SATO VICKI L (1197020) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/17/2025 5:46 PM | Eisner Mark (1834161) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 07/17/2025 3:18 PM | Eisner Mark (1834161) Reporting Vir Biotechnology (1706431) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 07/15/2025 7:11 PM | Eisner Mark (1834161) Reporting Vir Biotechnology (1706431) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/11/2025 4:59 PM | SCANGOS GEORGE A (1202102) Reporting Vir Biotechnology (1706431) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/10/2025 4:04 PM | SCANGOS GEORGE A (1202102) Reporting Vir Biotechnology (1706431) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/09/2025 5:39 PM | MORE ROBERT J (1207792) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
| 06/09/2025 4:55 PM | SCANGOS GEORGE A (1202102) Reporting Vir Biotechnology (1706431) Subject | Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
| 06/06/2025 7:26 PM | BISCHOFBERGER NORBERT W (1190273) Reporting Vir Biotechnology (1706431) Issuer | Form 4 Statement of changes in beneficial ownership of securities | |
The REAL Reason Trump is Invading Iran (Ad) For a moment…
Forget about Trump’s ties to Israel.
Forget about reports of Iran’s nuclear program.
Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason. Click here to find out what it is. |